The relationship between pharmaceutical expenditure and life expectancy: evidence from 21 OECD countries

References

• Auster , R. D. , Leveson , I. and Sarachek , D. 1969 . The production of health: an exploratory study . Journal of Human Resources , 4 : 411 – 36 .
   Web of Science ®Google Scholar
• Babazono , A. and Hillman , A. L. 1994 . A comparison of international health outcomes and health care spending . International Journal of Technology Assessment Health Care , 10 : 376 – 81 .
   PubMedGoogle Scholar
• Crémieux , P.-Y. , Meilleur , M.-C. , Ouellette , P. , Petit , P. , Zelder , M. and Potvin , K. 2005 . Public and private pharmaceutical spending as determinants of health outcomes in Canada . Health Economics , 14 : 107 – 16 .
   PubMed Web of Science ®Google Scholar
• Grubaugh , S. G. and Santerre , R. E. 1994 . Comparing the performance of health care systems: an alternative approach . Southern Economic Journal , 60 : 1030 – 42 .
   Google Scholar
• Lichtenberg, F. R. (1996) The effect of pharmaceutical utilization and innovation on hospitalization and mortality, NBER Working Papers 5418, 1–35
   Google Scholar
• Lichtenberg , F. R. 2004 . Sources of U.S. longevity increase, 1960–2001 . The Quarterly Review of Economics and Finance , 44 : 369 – 89 .
   Google Scholar
• Miller , R. D. Jr and Frech III , H. E. 2000 . Is there a link between pharmaceutical consumption and improved health in OECD countries? . Pharmacoeconomics , 18 : 33 – 45 .
   PubMedGoogle Scholar
• OECD (2005) Health Data 2005, 1st edn, OECD, Paris
   Google Scholar
• Peltzman , S. 1987 . Regulation and health: the case of mandatory prescriptions and an extension . Managerial and Decision Economics , 8 : 41 – 6 .
   Google Scholar
• Shaw , J. W. , Horrace , W. C. and Vogel , R. J. 2005 . The determinants of life expectancy: an analysis of the OECD health data . Southern Economic Journal , 71 : 768 – 83 .
   Web of Science ®Google Scholar